Find out more about a compensated eczema study ($500)
compensation:$500 in the form of two visa gift cards
QR Code Link to This Post
Researchers at UCSF are looking for adults with moderate-to-severe eczema (atopic dermatitis) who are currently on Dupixent but not seeing enough improvement. The goal is to uncover new biological insights that could lead to better treatments.
Who may qualify:
Adults (ages 18-70) with moderate-to-severe eczema
Currently taking Dupixent (dupilumab), but it isn't working well for you
What it requires:
A single 40-minute visit to UCSF Dermatology and an optional second visit
Compensation: Qualifying participants will receive up to $500 for completing the study